Identity
- Security key
- 18213
- Ticker
- LTGO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-08-07
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- LTGO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,165,468,075.63
- Shares outstanding (class)
- —
- Shares outstanding (weighted)
- 60,153,191
- SIC
- —
- Employees
- —
- Location
- —
- Homepage
- https://www.latigobio.com
- Description
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Market cap and share counts drift.